Trial Profile
Efficacy and Safety of Magnesium Isoglycyrrhizinate Injection in Subjects With Acute Drug-induced Liver Injury: A multi-center, randomized, double-blind, positive control, phase III clinical trial
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 22 Jun 2018
Price :
$35
*
At a glance
- Drugs Isoglycyrrhizinate (Primary)
- Indications Liver injury
- Focus Therapeutic Use
- Sponsors Chia Tai Tianqing Pharmaceutical Group
- 22 Jun 2018 New trial record